Eggert Larry D, Wiedmeier Susan E, Wilson Janie, Christensen Robert D
NICU Development Team, Intermountain Health Care, Salt Lake City, Utah, USA.
Pediatrics. 2006 May;117(5):e855-62. doi: 10.1542/peds.2005-1338.
Kernicterus is a rare but devastating condition. The prevention of bilirubin-induced brain injury is based on the detection of infants at risk for developing severe hyperbilirubinemia. In an 18-hospital health system, Intermountain Health Care (IHC), we initiated a program of predischarge bilirubin screening of all neonates and coupled this with a results assessment using a percentile-based nomogram. Data during 2 periods of time, before versus after initiating the program, were compared to assess the effect of the program on significant hyperbilirubinemia and rehospitalization.
We conducted a historic cohort study involving all neonates delivered at > or =35 weeks' gestation, within IHC's 18-hospital system, during 2 periods of time: March 1, 2001, to December 31, 2002, versus January 1, 2003, to December 31, 2004. A bilirubin screening program, instituted in December 2002, called for a total serum bilirubin (TSB) or transcutaneous bilirubin measurement to be performed on every neonate either at the recognition of clinical jaundice or before discharge regardless of whether jaundice was observed. For nonjaundiced neonates, the nursery staff was encouraged to obtain the screening TSB at the same time they obtained the state-mandated newborn screen for inborn errors of metabolism. Bilirubin values were plotted on an hour-specific nomogram and the corresponding percentile was used to guide evaluation, therapy, and follow-up. This study compared TSB data and readmission data for a 2-year period before versus a 2-year period after implementing the program.
The study involved 101272 neonates: 48789 in period 1 and 52483 in period 2. Before the program, 1 in every 77 neonates born at an IHC hospital had 1 or more serum bilirubin levels >20 mg/dL. After initiating the program, the incidence fell to 1 in 142 and the number of neonates with a level >25 mg/dL fell from 1 in 1522 before to 1 in 4037 after. The rate of hospital readmission with a primary diagnosis of jaundice fell from 0.55% in period 1 to 0.43% in period 2.
Initiating a program of bilirubin screening in a multihospital health system, coupled with evaluating the results using a percentile-based nomogram, reduced the proportion of neonates with significant hyperbilirubinemia and reduced the rate of hospital readmissions with jaundice.
核黄疸是一种罕见但具有毁灭性的病症。预防胆红素所致脑损伤的基础是识别有发生严重高胆红素血症风险的婴儿。在一个由18家医院组成的医疗系统——山间医疗保健公司(IHC)中,我们启动了一项对所有新生儿出院前进行胆红素筛查的项目,并结合使用基于百分位数的列线图进行结果评估。比较了该项目启动前后两个时间段的数据,以评估该项目对显著高胆红素血症和再次住院的影响。
我们进行了一项历史性队列研究,纳入了在IHC的18家医院系统内、孕周≥35周的所有新生儿,研究时间段为:2001年3月1日至2002年12月31日,以及2003年1月1日至2004年12月31日。2002年12月启动的一项胆红素筛查项目要求,无论是否观察到黄疸,在识别临床黄疸时或出院前对每个新生儿进行总血清胆红素(TSB)或经皮胆红素测量。对于无黄疸的新生儿,鼓励新生儿室工作人员在进行州规定的先天性代谢缺陷新生儿筛查的同时进行筛查TSB测量。将胆红素值绘制在特定小时的列线图上,并使用相应的百分位数来指导评估、治疗和随访。本研究比较了实施该项目前两年和实施后两年的TSB数据和再入院数据。
该研究纳入了101272名新生儿:第1阶段有48789名,第2阶段有52483名。在该项目实施前,IHC医院每77名出生的新生儿中就有1名血清胆红素水平达到或超过20mg/dL。项目启动后,这一发生率降至1/142,胆红素水平>25mg/dL的新生儿数量从之前的1/1522降至之后的1/4037。以黄疸为主要诊断的医院再入院率从第1阶段的0.55%降至第2阶段的0.43%。
在多医院医疗系统中启动胆红素筛查项目,并结合使用基于百分位数的列线图评估结果,可降低显著高胆红素血症新生儿的比例,并降低黄疸导致的医院再入院率。